European Medicines Agency (EMA)

Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines

European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines

European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants

Europe Holds Second COVID-19 Booster Dose For People Aged Under 80 Years

Deciphera Presents New Data Across Pipeline At ESMO Congress

Europe Holds Second COVID-19 Booster Dose For People Aged Under 80 Years

|

Deciphera Presents New Data Across Pipeline At ESMO Congress

|

Akouos' Hearing Loss Gene Therapy Poised To Receive Orphan Drug Tag In Europe

|

Moderna's COVID-19 Shot Gets EMA's Backing For Use In Adolescents

|

European Medicines Agency (EMA) Recent News

Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod

|

After FDA Warning, EMA Reviewing J&J COVID-19 Jab For Rare Nerve Disorder: Reuters

|

Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder

|

Stealth BioTherapeutics Stock Surges On Elamipretide's European Orphan Drug Tag for Ultra-Rare Genetic Condition

|

Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe

|

Janssen's Multiple Sclerosis Treatment Scores European Approval

|

Merck's Keytruda/Chemo Combo Therapy Wins EU Backing For Esophageal Cancer

|

EMA Grants BioMarin's Request For Speedy Review of Hemophilia A Gene Therapy

|

Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings

|

Myovant Sciences' Relugolix Combo Tablet For Uterine Fibroids Scores EMA Backing For Approval

|

Genmab - Janssen's Darzalex Wins Positive Opinion In Europe For Two New Indications

|

Larimar Shares Trade Higher On $95M Capital Raise, CTI-1601's Priority Medicines Tag In Europe

|

Albireo's Bylvay Wins Positive Opinion from EMA For Rare Pediatric Liver Disease

|

GlaxoSmithKline - Vir Biotech's Antibody COVID-19 Treatment Wins CHMP's Positive Scientific Opinion

|

Bluebird bio's Neurological Disorder Gene Therapy Wins CHMP Backing for Approval

|

European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters

|

EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots

European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca P

|

Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion

|

EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning

|

European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters

|

Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC

|

Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots

The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed&nbs

|

AbbVie Files US, Europe Applications For Skyrizi In Psoriatic Arthritis

|